Target Name: ZNF254
NCBI ID: G9534
Review Report on ZNF254 Target / Biomarker Content of Review Report on ZNF254 Target / Biomarker
ZNF254
Other Name(s): BMZF5 | hematopoietic cell-derived zinc finger protein 1 | zinc finger protein 254 | HD-ZNF1 | Zinc finger protein 91-like | CTD-2017D11.1 | bone marrow zinc finger 5 | ZNF254 variant 4 | ZNF539 | zinc finger protein 539 | ZN254_HUMAN | Zinc finger protein 254, transcript variant 4 | Hematopoietic-derived zinc finger protein | BMZF-5 | ZNF91L | Zinc finger protein 254 | Zinc finger protein 254 (isoform b) | Bone marrow zinc finger 5 | Hematopoietic cell-derived zinc finger protein 1 | Zinc finger protein 539

ZNF254: A Potential Drug Target for Chronic Inflammation and Cell Survival

ZNF254 (BMZF5) is a protein that is expressed in a variety of tissues, including the brain, heart, and kidneys. It is a member of the nuclear factor of activated T cells (NFAT) family, which is a group of transcription factors that play a role in the development and regulation of tissues and organs.

One of the functions of NFAT transcription factors is to regulate the expression of genes that are involved in cell signaling pathways and development. ZNF254 is involved in the regulation of several different processes in the body, including cell proliferation, differentiation, and survival.

One of the unique features of ZNF254 is its ability to interact with other transcription factors and proteins. This interaction allows it to regulate the activity of a wide range of genes, and it is thought to be a key factor in the regulation of tissues and organs during development and maintenance.

In addition to its role in cell signaling pathways, ZNF254 is also being studied as a potential drug target. The development of new treatments for a variety of diseases is often based on the identification of proteins that are involved in the disease process, and ZNF254 is one of these proteins.

One of the reasons why ZNF254 is being targeted as a drug target is its involvement in the regulation of inflammation. Chronic inflammation is thought to play a role in the development of a wide range of diseases, including heart disease, diabetes, and cancer.

Studies have shown that ZNF254 is involved in the regulation of the production of pro-inflammatory cytokines, which are molecules that play a key role in the inflammatory response. By suppressing the activity of ZNF254, researchers are working to develop new treatments for chronic inflammation.

Another potential drug target for ZNF254 is its role in the regulation of cell survival. Prolonged exposure to stress and environmental toxins can lead to the death of cells, and ZNF254 is involved in the regulation of cell survival in response to these stimuli.

Research is also being conducted to determine the role of ZNF254 in the regulation of cellular processes that are important for tissue repair and regeneration. Chronic injuries and diseases can result in the loss of cells, and ZNF254 may play a key role in the regulation of the repair and regenerative processes that are necessary to restore tissue function.

In conclusion, ZNF254 is a protein that is involved in a wide range of processes in the body, including cell signaling pathways, inflammation, and cell survival. Its unique ability to interact with other transcription factors and proteins makes it an attractive target for drug development, particularly for the treatment of chronic inflammation and diseases that result from the loss of cells. Further research is needed to fully understand the role of ZNF254 in these processes, and to develop new treatments based on its properties.

Protein Name: Zinc Finger Protein 254

Functions: May be involved in transcriptional regulation

The "ZNF254 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF254 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398